Reata Pharmaceuticals, Inc. (NASDAQ:RETA)

About the company

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

220

CEO

J. Warren Huff

Exchange

NASDAQ

Website

http://www.reatapharma.com

$20.00M

Total Revenue

220

Employees

$5B

Market Capitalization

-15.52

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$-74M

Operating Margin (in %)

Total operating margin

$-29M

Net Margin (in %)

Total net margin

$-30M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 153076.50 23087.00 51.95 26.98 23.97
AbbVie, Inc. ABBV 146930.84 34057.00 -23.52 17.52 24.65
Bristol Myers Squibb Co. BMY 113009.51 31006.00 2.74 96.08 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3748.16 1.00 34.65 -5.73 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1590.96 30.00 5.67 -22.64 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1360.91 341.00 2.79 -48.38 -8.59
Tricida, Inc. TCDA 1310.26 None 6.74 -6.20 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 712.58 14.00 4.60 -14.46 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 554.61 None 5.57 -9.64 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
Biospecifics Technologies Corp. BSTC 466.97 40.00 3.79 19.97 61.80
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 379.08 6.00 4.15 -4.13 None
Relmada Therapeutics, Inc. RLMD 373.32 0.00 5.57 -31.19 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 321.75 None 7.61 -4.93 None
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 300.30 4.00 9.48 -3.74 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Lannett Co., Inc. LCI 270.18 542.00 0.92 -8.89 -5.77
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Spero Therapeutics, Inc. SPRO 261.63 12.00 3.44 -3.22 -656.72
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Gritstone Oncology, Inc. GRTS 227.88 4.00 2.04 -2.18 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 219.60 12.00 2.43 -6.78 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
PhaseBio Pharmaceuticals, Inc. PHAS 126.73 2.00 2.35 -2.65 None
NeuBase Therapeutics, Inc. NBSE 123.62 None 51.94 -2.77 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Baudax Bio, Inc. BXRX 67.32 None -1.83 -0.96 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 58.32 192.00 1.01 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
Oncternal Therapeutics, Inc. ONCT 33.54 3.00 4.30 -1.33 -225.89
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.30 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Reata Announces Promotion and New Hires For Key Leadership Roles

23h ago, source: Associated Press

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the expansion of its leadership team and the appointment of ...

Reata Pharmaceuticals, Inc. Closes $350 Million Strategic Investment From Blackstone Life Sciences

13d ago, source: YAHOO!

This financing includes $300 million in return for single-digit royalty payments on worldwide net sales of bardoxolone methyl (“bardoxolone”) by Reata and its licensees, other than Kyowa Kirin Co., ...

Reata Pharmaceuticals Inc. Cl A

2d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Reata Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims

7d ago, source: YAHOO!

NEW YORK, NY / ACCESSWIRE / June 30, 2020 / Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Reata Pharmaceuticals, Inc.

Why Is Reata Pharmaceuticals, Inc. (RETA) Down 19.8% Since Last Earnings Report?

27d ago, source: Nasdaq

It has been about a month since the last earnings report for Reata Pharmaceuticals, Inc. (RETA). Shares have lost about 19.8% in that time frame, underperforming the S&P 500. Will the recent ...

CNS Pharmaceuticals Engages Berry Consultants to Advise Phase 2 Trial Design

7d ago, source: YAHOO!

CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc. related to a completed Phase 1 trial with ...

Reata Pharmaceuticals, Inc. Closes $350 Million Strategic Investment From Blackstone Life Sciences

13d ago, source: MarketWatch

The MarketWatch News Department was not involved in the creation of this content. PLANO, Texas, Jun 24, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) ("Reata" or ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.